Pharmaceutically active pyrrolidine derivatives

Details Pharmaceutically active pyrrolidine derivatives Pharmaceutically active pyrrolidine derivatives

2007-05-01

2007-05-01

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S536000, C548S537000

Reexamination Certificate

active

10239912

ABSTRACT:
The present invention is related to pyrrolidine derivatives of formula (I). Saidcompounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine derivatives of formula (I) are useful in the treatment and/or prevention of premature labor, premature birth and dysmenorrhea. In particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor. More preferably, said compounds are useful in the treatment and/or prevention of disease states mediated by oxytocin, including premature labor, premature birth and dysmenorrhea. The present invention is furthermore related to novel pyrrolidine derivatives as well as to methods of their preparation, wherein X is selected from the group consisting of CR6R7, NOR6, NNR6R7; A is selected from the group consisting of —(C═O)—, —(C═O)—O—, —C(═NH)—, —(C═O)—NH—, —(C═S)—NH, —SO22-, —SO2NH—, —CH2-, B is either a group —(C═O)—NR8R9 or represents a heterocyclic residue having the formula (a) wherein Q is NR10, O or S; n is an integer selected of 0, 1 or 2; Y, Z and E form together with the 2 carbons to which they are attached a 5–6 membered aryl or heteroaryl ring.

REFERENCES:
patent: 3555007 (1971-01-01), Magerlein
patent: 3674647 (1972-07-01), Visser
patent: 5756497 (1998-05-01), Bell et al.
patent: 6476026 (2002-11-01), Bryant et al.
patent: 1118306 (1968-06-01), None
patent: WO 95/04718 (1995-02-01), None
patent: WO 96/22775 (1996-08-01), None
patent: WO 99/52868 (1999-10-01), None
patent: WO 00/08015 (2000-02-01), None
Bryant et al., STN International (2005), CAPLUS Database, Columbus, OH, Accession No. 2000:666701, Registry No. 294621-30-0.
Bryant et al., STN International (2005), CAPLUS Database, Columbus, OH, Accession No. 2000:666701).
Sufrin et al. “Synthetic Approaches to Peptide Analogs Containing 4, 4-Difluoro-L-Proline and 4-Keto-L-Proline and4-L-proline.”Int. J. Pept. Protein Res. (1982), 20(5), 438-42.
Komai et al. “Structure-activity Relationships of HIV-1 PR Inhibitors Containing AHPBA-II. Modification of Pyrrolidine Ring at P1′ Proline”Bioorg. Med. Chem. (1996), 4(8), 1365-1377.
Narukawa et al. “General and Efficient Synthesis of 2-Alkylcarbapenems: Synthesis of Dethiacarba Analogs of Clinically Useful CarbapenemsviaPalladium-Catalyzed Cross-Coupling Reaction”Tetrahedron1(1997) 53(2): 539-556.
Nicolaides et al. “Modified Di- and Tripeptides of the C-Terminal Portion of Oxytocini and Vasopressin as Possible Cognition Activation Agents”Journal of Medicinal Chemistry, American Chemical Society(1986) 29(6) 959-971.
Adlington et al. “A radical Route to 2(S)-4-Exomethylene Proline”Tetrahedron(1992) 48(31): 6529-6536.
Holmes et al. “The Design and Synthesis of Novel Hydroxyproline Inhibitors of HIV-1 Proteinase”Bioorganic&Medical Chemistry Letters(1993) 3(8): 1485-1491.
Maggi et al. “Human Myometrium during Pregnancy Contains and Responds to V1 Vasopressin Receptors as well as Oxytocin Receptors”Journal of Clinical Endocrinology and Metabolism(1990) 70(4): 1142-1154.
Evans et al. “Orally Active, Nonpeptide Oxytocin Antagonists”J. Med. Chem. (1992) 35: 3919-3927.
Pedersen et al. “Studies on Organophosphorus Compunds XX. Syntheses of Thioketones”Bull. Soc., Chim. Belg. vol. 87, No. 3, 1978.

Affiliated with

Also associated with

Rating

Pharmaceutically active pyrrolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically active pyrrolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically active pyrrolidine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3732571